Novavax COVID-19 vaccine (NVX-CoV2373)

SARS-CoV-2 recombinant spike protein vaccine, adjuvanted · Novavax, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Novavax COVID-19 vaccine (NVX-CoV2373), covering 2025-03-10 to 2025-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States [Phase 4]

See pricing